Table 7.
Morbidity and Mortality Risks of Pneumocystosis in At-Risk Patients (Healthcare Cost and Utilization Project, 2018), United States
| Infection | Average Cost of Visit (in $1,000) |
Average Length of Stay (Days) | Infection, No., Rate per 100 000 | Deaths, No., % Infected | Relative Risk of Mortality (95% CI) | Population, No. | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| – | + | Ratio | – | + | Ratio | |||||
| All visits with at-risk diagnoses | 30.47 | 70.84 | 2.39 | 5.54 | 12.32 | 2.30 | 9505 53.36 |
1210 12.73 |
3.94 (3.74–4.15) | 17 813 520 |
| Cancer | 77.95 | 196.44 | 2.52 | 6.02 | 14.74 | 2.45 | 1680 60.33 |
480 28.57 |
3.82 (3.54–4.16) | 2 784 530 |
| Leukemia | 110.63 | 274.85 | 2.48 | 8.16 | 18.33 | 2.25 | 415 154.91 |
85 20.48 |
3.92 (3.22–4.71) | 267 895 |
| Lung, trachea, bronchus | 69.25 | 161.30 | 2.33 | 6.00 | 14.36 | 2.39 | 225 57.01 |
85 37.78 |
4.37 (3.67–5.12) | 394 645 |
| Non-Hodgkin lymphoma | 89.85 | 195.98 | 2.18 | 6.55 | 14.44 | 2.20 | 555 278.80 |
100 18.02 |
3.84 (3.21–4.58) | 199 065 |
| COPD | 61.48 | 133.89 | 2.18 | 5.31 | 11.49 | 2.16 | 1310 28.86 |
200 15.26 |
4.38 (3.85–4.97) | 4 539 705 |
| HIV | 34.61 | 58.06 | 1.68 | 9.39 | 12.11 | 1.29 | 5990 4949.80 |
435 7.26 |
2.45 (2.23–2.70) | 121 015 |
| Influenza | 55.86 | 237.64 | 4.25 | 5.44 | 14.10 | 2.59 | 155 41.01 |
45 29.03 |
8.23 (6.41–10.46) | 377 950 |
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus.